$0.7503
0.02162.96%
Last update: Nov 9, 5:56 PM
Connect Biopharma Holdings Ltd
CNTBNASDAQ
Connect Biopharma fell 51.6% from $1.55 to $0.75, behind the S&P 500's +10.5%. Its worst day was Sep 15 (−32.2%), and its low came Nov 6 at $0.73.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.31 missed the $-0.27 estimate on $16,000.00 revenue.
+3.9% · S&P 500 +0.1%
EPS of $-0.27 beat the $-0.30 estimate on $0.00 revenue (est. $20,630.00).
Story events cover the past 12 months · Times ET
+3.8% · S&P 500 +0.8%
EPS of $-0.34 missed the $-0.28 estimate on $169,000.00 revenue.
+14.5% · S&P 500 −0.2%
Connect Biopharma shares rose 19.8%, while the S&P 500 rose 0.8%.
+19.8% · S&P 500 +0.8%
EPS of $-0.27 beat the $-0.31 estimate on $2.8M revenue (est. $4.1M).
+9.0% · S&P 500 +0.7%
Connect Biopharma shares fell 30.1%, while the S&P 500 rose 1.0%.
−30.1% · S&P 500 +1.0%
Connect Biopharma Holdings Limited (NASDAQ:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today
−32.2%, the year's worst day · S&P 500 −0.5%
Where it ended: a close of $0.75 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.26, revenue est. $4.7M).
Nothing in the past 12 months.
All CNTB dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CNTB and SPY from Benzinga historical bars. Not investment advice.
